Mirvetuximab soravtansine was the first ADC to show efficacy as a therapy for platinum-resistant ovarian cancer. Despite high ...

Discover how advances from various biotechs are bridging treatment gaps in menopause care, offering hope for managing ...

The first, called nirmatrelvir, blocks the activity of an enzyme the COVID-19 virus needs to copy itself, also called repl ...

Two specialists are impressed by the preliminary findings of a randomized trial in newly diagnosed patients, but another is ...

Researchers at ETH Zurich have used a drug screening platform they developed to show that an antidepressant, currently on the ...

Vortioxetine, an antidepressant, shows promise against glioblastoma in lab tests conducted by ETH Zurich, leading to forthcoming clinical trials. Glioblastoma is an incurable and fatal type of brain ...

The most common breast cancer is HER2-negative, so called because it has low amounts of one of the proteins that contribute to tumor cell growth, HER2. Despite this common trait, the development of ...

A nationwide clinical trial shows positive results for cancer patients with this common wasting syndrome. Researchers discovered a drug that safely and effectively helped cancer patients when they ...

A biotech that uses artificial intelligence to assist its drug discovery efforts has relocated its headquarters from New York ...

Kineta will be trading under the symbol “KANT” on OTC PinkKineta will continue to pursue strategic alternatives as previously announcedTuHURA ...

Researchers discovered a drug that safely and effectively helped cancer patients when they suffered from cachexia (ku-KEK-see-uh), a common condition related to cancer that involves weight loss and ...

Earlier this week, we took a look at Argenica Therapeutics (ASX:AGN), a brain injury-focused clinical-stage biotech ...